. Apolipoproteins A1/B Sample Type: Serum

Apolipoproteins A1 and B (ApoA1 / ApoB): Clinical Insight Introduction Apolipoproteins are the protein components of lipoproteins and are critical to lipid transport and metabolism. Two of the most clinically significant apolipoproteins are ApoA1 and ApoB, which serve as markers of “good” and “bad” cholesterol transport, respectively. Apolipoprotein A1 (ApoA1) is the main protein of high-density lipoprotein (HDL). Apolipoprotein B (ApoB) is the primary protein found in low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), and intermediate-density lipoprotein (IDL). Together, their measurement offers a superior assessment of cardiovascular risk compared to traditional lipid panels. Functions of ApoA1 and ApoB ApoA1 Major structural protein of HDL (good cholesterol). Promotes reverse cholesterol transport — removal of cholesterol from peripheral tissues to the liver. Activates LCAT (lecithin-cholesterol acyltransferase), which helps in HDL maturation. ApoB Primary structural protein of LDL, VLDL, and IDL (bad cholesterol particles). Facilitates delivery of cholesterol to peripheral tissues. Exists in two forms: ApoB-100 (found in LDL, VLDL) and ApoB-48 (in chylomicrons, not measured in standard blood tests). Sample Type Serum: Blood is drawn, allowed to clot, and centrifuged to separate the serum. This is the fluid used for testing ApoA1 and ApoB levels. Clinical Significance ApoA1 High levels = Protective against cardiovascular disease (CVD). Low levels = Associated with increased risk of atherosclerosis and coronary artery disease. ApoB High levels = Strong predictor of atherosclerotic cardiovascular disease (ASCVD). Each ApoB molecule represents one potentially atherogenic lipoprotein particle. ApoB/ApoA1 Ratio Considered a more accurate marker of cardiovascular risk than LDL or HDL levels alone. High ApoB/ApoA1 ratio suggests an imbalance between atherogenic and protective lipoproteins, indicating higher cardiovascular risk. Testing and Interpretation Normal Reference Ranges (may vary by lab): ApoA1: Men: 110–180 mg/dL Women: 120–205 mg/dL ApoB: Optimal: <90 mg/dL Moderate risk: 90–110 mg/dL High risk: >110 mg/dL ApoB/ApoA1 Ratio Interpretation: <0.6 = Low risk 0.6–0.8 = Moderate risk >0.8 = High risk Advantages Over Traditional Lipid Testing Reflects actual number of lipoprotein particles (ApoB). Better assessment of atherogenic burden. More reliable in patients with metabolic syndrome, diabetes, or normal LDL-C but high cardiovascular risk. Factors Affecting Levels Increased ApoB: High-fat diets, obesity, diabetes, hypothyroidism Decreased ApoA1: Smoking, sedentary lifestyle, liver disease Increased ApoA1: Exercise, estrogen therapy, statins Conclusion Simultaneous measurement of ApoA1 and ApoB provides a comprehensive picture of lipoprotein balance and cardiovascular risk. The ApoB/ApoA1 ratio is especially useful for identifying individuals at high risk of atherosclerosis, even when standard cholesterol levels appear normal.